-
COMPARATOR SELECTION UNDER EU JOINT CLINICAL ASSESSMENT: IMPLICATIONS FOR PICO SCOPING, PICO CONSOLIDATION AND EVIDENCE GENERATION PLANS
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF EARLY DIAGNOSIS AND IMMUNOGLOBULIN TREATMENT FOR INBORN ERRORS OF IMMUNITY WITH FOCUS ON COMMON VARIABLE IMMUNODEFICIENCY (CVID) IN BRAZIL: A COST-EFFECTIVENESS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
AVAILABILITY AND PRICES OF LOCALLY PRODUCED AND IMPORTED ANTI-CANCER MEDICINES IN PAKISTAN
Aug 11, 2026, 17:16 PM -
DRIVERS OF NICE ACCEPTANCE FOR HIGH ICER VALUES: A COMPARATIVE ANALYSIS OF TECHNOLOGY APPRAISALS (TA)
Aug 11, 2026, 17:16 PM -
CGVHD HEALTHCARE PATHWAY, UNMET NEED AND ECONOMIC BURDEN IN ALGERIA: A FIRST PHARMACOECONOMIC STUDY
Aug 11, 2026, 17:16 PM -
PEDIATRIC LIVER TRANSPLANTATION IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS): REAL-WORLD RESOURCE UTILIZATION AND CLINICAL OUTCOMES (2015-2025)
Aug 11, 2026, 17:16 PM -
RELATIONSHIP BETWEEN LOWER LIMB FUNCTIONAL PARAMETERS, PHYSICAL PERFORMANCE AND INJURY RISK INDICATORS IN U9-U13 ATHLETES
Aug 11, 2026, 17:16 PM -
IMPROVING ASTHMA OUTCOMES WHILE REDUCING COSTS: A VALUE-DRIVEN CARE PATHWAY AT A SINGAPORE TERTIARY HOSPITAL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVE INTERVENTIONS TO PREVENT ADOLESCENT SELF-HARM AND SUICIDE: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
IS EUROPE BECOMING A LATER REGULATORY LAUNCH MARKET? TRENDS IN EMA AUTHORISATION AFTER FDA APPROVAL
Aug 11, 2026, 17:16 PM -
NOT A SUBMISSION, A SYSTEM: JOINT CLINICAL ASSESSMENT AS AN ENTERPRISE CAPABILITY
Aug 11, 2026, 17:16 PM -
TRANSFORMING PRE-LAUNCH FORECASTING: AN AGENTIC AI PLATFORM FOR TRANSPARENT SCENARIO PLANNING IN PHARMA
Aug 11, 2026, 17:16 PM -
CAPTURING THE PATIENT PERSPECTIVE: TARGETED LITERATURE REVIEW FINDINGS ON THE CRITICAL ROLE OF PROS IN ONCOLOGIC AMNOG EVALUATIONS
Aug 11, 2026, 17:16 PM -
IMPACT OF THE 2026 UK EQ-5D-5L VALUE SET ON UTILITY ESTIMATES IN LUPUS RASH AND CUTANEOUS LUPUS ERYTHEMATOSUS
Aug 11, 2026, 17:16 PM -
HOW CTDNA AND UTDNA ARE RESHAPING TREATMENT PATHWAYS IN BLADDER CANCER: IMPLICATIONS FOR EARLY ACCESS, HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REIMBURSEMENT
Aug 11, 2026, 17:16 PM -
THE IMPACT ON NHS CAPACITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ISATUXIMAB IN THE UK
Aug 11, 2026, 17:16 PM -
APPLYING TARGET TRIAL EMULATION TO MULTIDRUG-RESISTANT GRAM-NEGATIVE INFECTIONS IN THE INTENSIVE CARE UNIT: A PRACTICAL FRAMEWORK
Aug 11, 2026, 17:16 PM -
A DECADE OF THE RECOVERING QUALITY OF LIFE (REQOL) QUESTIONNAIRE: UPTAKE AND USE OF A RECOVERY-ORIENTED QUALITY OF LIFE MEASURE IN MENTAL HEALTH CLINICAL RESEARCH
Aug 11, 2026, 17:16 PM -
IMPACT OF ENDPOINT SELECTION ON COMPARATIVE EFFICACY CONCLUSIONS IN CROHN'S DISEASE (CD)
Aug 11, 2026, 17:16 PM -
SYSTEMATIC VERSUS ETIOLOGY-RESTRICTED FABRY DISEASE SCREENING IN MOROCCO'S DIALYSIS POPULATION: A DECISION-TREE COST-UTILITY ANALYSIS BENCHMARKED ON A DIALYSIS-REVEALED THRESHOLD
Aug 11, 2026, 17:16 PM
